Table 4

- Variants detected in compound heterozygous state in 15 patients with Wilson disease.

Pt’s IDFirst variantEffect / ClassificationSecond variantEffect / ClassificationPresentationScore after NGS
2#c.3517G>A (p.Glu1173Lys)Missense/pathogenicc.4051C>T (p.Gln1351Ter)Stop-gain / pathogenicHepatic10
3c.1924G>C (p.Asp642His)Missense/pathogenicc.1870-39T>C (Intronic variant)Intronic / Likely pathogenicMixed11
7c.2332C>G (p.Arg778Gly)Missense/pathogenicc.562C>T (p.Gln188Ter)Stop-gain / pathogenicHepatic9
9c.4092-4093delGT (p.Ser1365CysfsTer12)Frameshift/pathogenicc.3556G>A (p.Gly1186Ser)Missense / pathogenicHepatic8
11c.3955C>T (p.Arg1319Ter)Stop-gain / pathogenicc.3472-3482del GGTTTAACCAT (p.Gly1158PhefsTer2)Frameshift / pathogenicMixed8
12c.3538A>G (p.Ile1180Val)Missense/likely pathogenicc.2730+39-2730+41delGTT (Intronic deletion)Intronic deletion / Likely pathogenicMixed10
19c.3649-3654del GTTCTG (p.Val1217-Leu1218del)Inframe-deletion / pathogenicc.2804C>T (p.Thr935Met)Missense / pathogenicMixed10
20c.3960G>C (p.Arg1320Ser)Missense/ pathogenicc.3121C>T (p.Arg1041Trp)Missense / likely pathogenicHepatic7
28c.3317T>A (p.Val1106Asp)Missense / likely pathogenicc.3263T>A (p.Leu1088Ter)Stop-gain / pathogenicMixed10
32c.2972C>T (p.Thr991Met)Missense/ pathogenicc.2297C>G (p.Thr766Arg)Missense / pathogenicHepatic7
42c.3182G>A (p.Gly1061Glu)Missense/ pathogenicc.1924G>T (p.Asp642Tyr)Missense / pathogenicHepatic8
44c.2827G>A (p.Gly943Ser)Missense/ pathogenicc.2530A>T (p.Lys844Ter)Stop-gain / PathogenicHepatic6
46c.1708-1G>A (Splice acceptor variant)Splice acceptor/ pathogenicc.1543+1G>C (Splice donor variant)Splice donor / pathogenicHepatic9
47c.3443T>C (p.Ile1148Thr)Missense/ pathogenicc.2333G>T (p.Arg778Leu)Missense / pathogenicNeuro8
49c.2930C>T (p.Thr977Met)Missense/ pathogenicc.2549C>T (p.Thr850Ile)Missense / pathogenicHepatic7

NGS: next-generation sequencing

  • # This patient had additional third variant, c.2447+11delG (intronic variant, classified as likely pathogenic).